Clinical Trial Update: A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration [Phase 1]

View source ↗

Summary

This update describes a Phase 1 follow-up study to evaluate the safety of RetinoStat in Age-related macular degeneration, with the trial currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• RetinoStat

Snippet

Sponsor: Oxford BioMedica | Conditions: Age-Related Macular Degeneration | Phase 1 | Status: ACTIVE_NOT_RECRUITING